CMT Awareness Month in the US

September marks CMT Awareness month in the United States. The Hereditary Neuropathy Foundation (HNF) describes CMT as “the biggest disease most people have never heard of.’ The majority of people - including many doctors and people with undiagnosed CMT - are largely unaware of the disease.

Charcot-Marie-Tooth disease was identified in 1886. However for the next 120 years there was no organized effort to help find an effective treatment – even though CMT affects nearly 3 million people around the world.

At NMD Pharma, we are committed to changing this. Read about our innovative approach to finding a break-through therapy here

Previous
Previous

NMD Pharma will be at LSX Nordic Congress

Next
Next

NMD Pharma at ICFSR 2022 - Symposium 4 - Part 1